Back
Gain Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
GANX
Gain Therapeutics, Inc.
Last Price:
$3.21
Seasonality Move:
19.87%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and GANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Gain Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.55 | Sell |
| 20-day SMA: | 3.5 | Sell |
| 50-day SMA: | 2.72 | Buy |
| 200-day SMA: | 2.05 | Buy |
| 8-day EMA: | 3.36 | Sell |
| 20-day EMA: | 3.36 | Sell |
| 50-day EMA: | 2.74 | Buy |
| 200-day EMA: | 1.2 | Buy |
Gain Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 49.21 | Sell |
| Chaikin Money Flow: | 1754739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.8 - 3.92) | Sell |
| Bollinger Bands (100): | (1.49 - 2.99) | Buy |
Gain Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Gain Therapeutics, Inc. Stock
Is Gain Therapeutics, Inc. Stock a Buy?
-
Gain Therapeutics, Inc. share price is 3.19 while GANX 8-day simple moving average is 3.55, which is a Sell signal.
-
The stock price of GANX is 3.19 while Gain Therapeutics, Inc. 20-day SMA is 3.50, which makes it a Sell.
-
Gain Therapeutics, Inc. 50-day simple moving average is 2.72 while GANX share price is 3.19, making it a Buy technically.
-
GANX stock price is 3.19 and Gain Therapeutics, Inc. 200-day simple moving average is 2.05, creating a Buy signal.
GANX Technical Analysis vs Fundamental Analysis
Sell
44
Gain Therapeutics, Inc. (GANX)
is a Sell
Is Gain Therapeutics, Inc. a Buy or a Sell?
-
Gain Therapeutics, Inc. stock is rated a SellThe current Gain Therapeutics, Inc. [GANX] share price is $3.19. The Score for GANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Gain Therapeutics, Inc. Stock Info
Market Cap:
115.6M
Price in USD:
3.19
Share Volume:
2.9M
Gain Therapeutics, Inc. 52-Week Range
52-Week High:
4.34
52-Week Low:
1.41
Sell
44
Gain Therapeutics, Inc. (GANX)
is a Sell
Gain Therapeutics, Inc. Share Price Forecast
-
What is the Gain Therapeutics, Inc. stock price today?The Gain Therapeutics, Inc. stock price is 3.19 USD today.
-
Will GANX stock go up or go down?Gain Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Gain Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Gain Therapeutics, Inc. is overvalued.
Is Gain Therapeutics, Inc. Stock a Buy?
-
Gain Therapeutics, Inc. share price is 3.19 while GANX 8-day exponential moving average is 3.36, which is a Sell signal.
-
The stock price of GANX is 3.19 while Gain Therapeutics, Inc. 20-day EMA is 3.36, which makes it a Sell.
-
Gain Therapeutics, Inc. 50-day exponential moving average is 2.74 while GANX share price is 3.19, making it a Buy technically.
-
GANX stock price is 3.19 and Gain Therapeutics, Inc. 200-day simple moving average is 1.20, creating a Buy signal.
Fundamental Analysis of Gain Therapeutics, Inc.
Is Gain Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Gain Therapeutics, Inc.
Should I short Gain Therapeutics, Inc. stock?
-
GANX Moving Average Covergence Divergence (MACD) indicator is 0.17, suggesting Gain Therapeutics, Inc. is a Buy
-
Gain Therapeutics, Inc. Relative Strength Index (RSI) is 49.21, which suggest Gain Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Gain Therapeutics, Inc. is (2.8 - 3.92), which suggest Gain Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Gain Therapeutics, Inc. is (1.49 - 2.99), which suggest Gain Therapeutics, Inc. is a Buy
* Gain Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.